drugset / Trial / NCT05810324
18F-FAPI PET/CT in Patients With Various Types of Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
To evaluate the potential usefulness of 18F-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2024-07-01
- Completion
- 2025-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FAPI | Diagnostic / imaging agent | — | Intravenous |